Amicus Therapeutics Inc (FOLD)
EBITDA Growth
-24.92%
Quarterly · Period ending:
FOLD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-24.92%period ending
Latest reported-24.92%period ending
FOLD Quarterly EBITDA YoY % (-132.05% → -24.92%)
Year-over-year change
High-resolution chart · PNG
FOLD ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -24.9168% | |
| 121.0884% | |
| -138.9407% | |
| 83.6064% | |
| 231.7218% | |
| 328.0792% | |
| 157.3299% | |
| 27.7307% | |
| 71.1286% | |
| 48.2977% | |
| 50.0165% | |
| 44.1976% | |
| 18.3264% | |
| 54.9974% | |
| -39.6723% | |
| -31.9477% | |
| -12.4964% | |
| 24.4667% | |
| 14.2224% | |
| 34.4285% | |
| 25.8073% | |
| 5.1196% | |
| 44.7633% | |
| 26.2606% | |
| -25.8408% | |
| 62.902% | |
| -39.4811% | |
| -145.7656% | |
| -4.6853% | |
| 44.2558% | |
| -29.852% | |
| 7.9722% | |
| -9.0486% | |
| -518.5823% | |
| 11.2192% | |
| -18.4204% | |
| -47.9092% | |
| -19.0061% | |
| -83.5792% | |
| -79.7377% | |
| -84.4148% | |
| -127.4071% | |
| -90.6417% | |
| -54.2435% | |
| -67.3591% | |
| -16.1662% | |
| 6.8502% | |
| 10.7766% | |
| 0.7997% | |
| 10.701% | |
| -67.567% | |
| -34.2039% | |
| -6.4413% | |
| -69.5624% | |
| 27.0084% | |
| 1.477% | |
| 23.7328% | |
| 36.7591% | |
| -13.4576% | |
| -2.4449% | |
| -147.6417% | |
| -15.6133% | |
| 17.8596% | |
| -5.1851% | |
| 333.19% | |
| -43.3666% | |
| -28.5855% | |
| -33.1326% | |
| -9.4913% | |
| 22.4001% | |
| -1.8753% | |
| 9.7433% | |
| -13.6694% | |
| 0.8219% | |
| 13.9323% | |
| 14.2516% | |
| -132.0461% | |
| -132.0461% | |
| -132.0461% | |
| -132.0461% |